600993.SH
Mayinglong Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 24.01
−0.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 15.57x
- P/E 2027E
- 14.02x
- P/E 2028E
- 12.66x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.80x
- PEG TTM
- 2.57x
- Price / book
- 2.33x
- Price / sales
- 2.65x
- Price / cash flow
- 15.12x
Enterprise value
- Enterprise value
- CNY 9.6B
- EV / sales
- 2.46x
- EV / EBITDA
- 12.15x
- EV / EBIT
- 13.18x
- Market cap
- CNY 10.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026